gmi research logo
GMI Research
See the Future Insights
GMI Research Facebook Page GMI Research Twitter Page GMI Research Linkedin Page
U.S Office +1 860 881 2270 : Europe Office +353 1 442 8820  

Global Biopharmaceuticals Market by Product Type (Monoclonal Antibody, Interferon, Insulin, Growth Factor, Erythropoietin, Vaccine, Hormone And Others), by Therapeutic Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology and Others) and by Geography - Opportunities & Forecast, 2018-2025

Get Free 20% Customization in this Report


Report Code : Published Date: Report Format: PPT

 

Select License Type:

Need Assitance ?


A GMI Research Sales Representative
is available to help you

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820


Biopharmaceuticals are large molecules, used as medicinal drugs. Biopharmaceutical drugs are produced through complex biotechnological methods involving recombinant DNA techniques, hybridoma techniques, and purification processes. Biopharmaceutical production involves the use of living microorganisms, plants, or animal cells. These drugs help in prevention and treatment of various diseases such as cardiovascular disease, rheumatoid arthritis, psoriatic arthritis, psoriasis, anaemia arising from chemotherapy, chronic renal failure, cancer, and diabetes. Technological advancements in biopharmaceuticals have revolutionized the treatment of many serious and chronic illnesses, based on which the demand for biopharmaceutical products would greatly be boosted during the forecasted period. There are more than 300 approved biopharmaceutical drugs; the anti-inflammatory drug Humira is one of the best-selling drugs worldwide.

Factors such as increasing incidence of chronic diseases, rising geriatric population and increased R&D investments for formulation and development of biologics are fuelling the growth of the biopharmaceutical market during the forecasted period. Currently more than thousand large molecules are undergoing clinical trials. Furthermore, the rise in strategic collaborations between biopharmaceutical companies and Contract Research Organization & Contract Manufacturing Organization is also expected to spur the growth of the biopharmaceutical market. In addition, technological advancement in biopharmaceutical manufacturing and expansion of biosimilar are also helping to boost the demand of biopharmaceutical products during the forecasted period. However, cost containment, stringent regulation are some factors, which are restraining the growth of the biopharmaceuticals market.

Various notable players operating in the market, include Sanofi, F. Hoffmann-La Roche, AbbVie Inc, Pfizer, Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline, Eli Lilly and Company, AstraZeneca PLC, Bayer AG among others. Major players are focussing on R&D activities and strategic acquisition and merger activities to hold their leadership in this market. For instance, in 2018, Sanofi acquired Ablynx to expands growing rare blood disorders franchise with Ablynx's late-stage investigational caplacizumab.

The global biopharmaceuticals market has been segmented on the basis of product type, therapeutics application and key geographies. Based on product type, the market comprises of tissue intravascular cooling and intravascular warming. The research report “global biopharmaceuticals market” provides in-depth analysis of global biopharmaceuticals market based on product type, therapeutics application and major geographies for the forecasted period, from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global biopharmaceuticals market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1-    At what pace is biopharmaceuticals market growing? What will be growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the biopharmaceuticals market?
4-    What are the various application areas and how they are poised to grow?

Market Segmentation


By Product Type
•    Monoclonal antibody
•    Interferon
•    Insulin
•    Growth factor
•    Erythropoietin
•    Vaccine
•    Hormone
•    Others

By Therapeutic Application
•    Oncology
•    Blood disorder
•    Metabolic disease
•    Infectious disease
•    Cardiovascular disease
•    Neurological disease
•    Immunology
•    Others

By Geography
•    North America
As a part of customization
      o    By Product Type
      o    By Therapeutics Application
      o    US
      o    Canada
      o    Mexico
•    Europe

As a part of customization
      o    By Product Type
      o    By Therapeutics Application
      o    UK
      o    Germany
      o    Spain
      o    Rest of Europe
 

•    Asia-Pacific

As a part of customization
      o    By Product Type
      o    By Therapeutics Application
      o    China
      o    Australia
      o    India
      o    Rest of APAC
•    ROW

As a part of customization
      o    By Product Type
      o    By Therapeutics Application
      o    Brazil
      o    South Africa
      o    GCC countries
      o    Rest of world (remaining countries of the LAMEA region)

Leading market players
•    Sanofi
•    F. Hoffmann-La Roche
•    AbbVie Inc.
•    Pfizer, Inc.
•    Merck & Co., Inc.
•    Novartis AG
•    Johnson & Johnson
•    GlaxoSmithKline
•    Eli Lilly and Company
•    AstraZeneca PLC,
•    Bayer AG

•     *Other prominent players in the market which can be profiled as a part of customization:
•    Amgen Inc.
•    Gilead Sciences
 

1.    Executive Summary

2.    Introduction    
       
       2.1.    Study Objectives       
       2.2.    Market Definition       
                  2.2.1.     Market Covered   
                  2.2.2.    Geographical Coverage   
                  2.2.3.    Study Years & Currency   
       2.3.    Market Stakeholders       
       2.4.    Key Questions this Study will Answer       
       2.5.    GMI Research’s Approach & Methodology  

3.    Global Biopharmaceuticals Market - Overview           
       3.1.    Introduction         `
       3.2.    Market Segmentation
       3.3.    Pipeline Analysis     
       3.4.    Drivers       
       3.5.    Restraints       
       3.6.    Trends     

4.    Global Biopharmaceuticals Market Revenue Forecast till 2025    

5.    Global Biopharmaceuticals Market by Product Type Revenue Forecast till 2025  
         
       5.1.    Monoclonal antibody
       5.2.    Interferon
       5.3.    Insulin
       5.4.    Growth factor
       5.5.    Erythropoietin
       5.6.    Vaccine
       5.7.    Hormone
       5.8.    Others

6.    Global Biopharmaceuticals Market by Therapeutic Application Revenue Forecast till 2025           
       6.1.    Oncology
       6.2.    Blood disorder
       6.3.    Metabolic disease
       6.4.    Infectious disease
       6.5.    Cardiovascular disease
       6.6.    Neurological disease
       6.7.    Immunology
       6.8.    Others


7.    Global Biopharmaceuticals Market by Geography Revenue Forecast till 2025
       7.1.    North America Biopharmaceuticals Market Revenue Forecast till 2025       
                  7.1.1.    North America Biopharmaceuticals Market by Product Type (Option 1: 25% customization)
                                7.1.1.1.    Monoclonal antibody
                                7.1.1.2.    Interferon
                                7.1.1.3.    Insulin
                                7.1.1.4.    Growth factor
                                7.1.1.5.    Erythropoietin
                                7.1.1.6.    Vaccine
                                7.1.1.7.    Hormone
                                7.1.1.8.    Others
                  7.1.2.    North America Biopharmaceuticals Market by Therapeutic Application
                                7.1.2.1.    Oncology
                                7.1.2.2.    Blood disorder
                                7.1.2.3.    Metabolic disease
                                7.1.2.4.    Infectious disease
                                7.1.2.5.    Cardiovascular disease
                                7.1.2.6.    Neurological disease
                                7.1.2.7.    Immunology
                                7.1.2.8.    Others

       7.2.    Europe Biopharmaceuticals Market Revenue Forecast till 2025       
                  7.2.1.    Europe Biopharmaceuticals Market by Product Type (Option 2: 25% customization)
                                7.2.1.1.    Monoclonal antibody
                                7.2.1.2.    Interferon
                                7.2.1.3.    Insulin
                                7.2.1.4.    Growth factor
                                7.2.1.5.    Erythropoietin
                                7.2.1.6.    Vaccine
                                7.2.1.7.    Hormone
                                7.2.1.8.    Others
                  7.2.2.    Europe Biopharmaceuticals Market by Therapeutic Application
                                7.2.2.1.    Oncology
                                7.2.2.2.    Blood disorder
                                7.2.2.3.    Metabolic disease
                                7.2.2.4.    Infectious disease
                                7.2.2.5.    Cardiovascular disease
                                7.2.2.6.    Neurological disease
                                7.2.2.7.    Immunology
                                7.2.2.8.    Others
 
       7.3.    Asia-Pacific Biopharmaceuticals Market Revenue Forecast till 2025       
                  7.3.1.    Asia-Pacific Biopharmaceuticals Market by Product Type (Option 3: 25% customization)
                                7.3.1.1.    Monoclonal antibody
                                7.3.1.2.    Interferon
                                7.3.1.3.    Insulin
                                7.3.1.4.    Growth factor
                                7.3.1.5.    Erythropoietin
                                7.3.1.6.    Vaccine
                                7.3.1.7.    Hormone
                                7.3.1.8.    Others
                  7.3.2.    Asia-Pacific Biopharmaceuticals Market by Therapeutic Application
                                7.3.2.1.    Oncology
                                7.3.2.2.    Blood disorder
                                7.3.2.3.    Metabolic disease
                                7.3.2.4.    Infectious disease
                                7.3.2.5.    Cardiovascular disease
                                7.3.2.6.    Neurological disease
                                7.3.2.7.    Immunology
                                7.3.2.8.    Others

       7.4.    Rest of the World Biopharmaceuticals Market Revenue Forecast till 2025       
                  7.4.1.    Rest of the World Biopharmaceuticals Market by Product Type

                                (Option 4: 25% customization)
                                7.4.1.1.    Monoclonal antibody
                                7.4.1.2.    Interferon
                                7.4.1.3.    Insulin
                                7.4.1.4.    Growth factor
                                7.4.1.5.    Erythropoietin
                                7.4.1.6.    Vaccine
                                7.4.1.7.    Hormone
                                7.4.1.8.    Others
                  7.4.2.    Rest of the World Biopharmaceuticals Market by Therapeutic Application
                                7.4.2.1.    Oncology
                                7.4.2.2.    Blood disorder
                                7.4.2.3.    Metabolic disease
                                7.4.2.4.    Infectious disease
                                7.4.2.5.    Cardiovascular disease
                                7.4.2.6.    Neurological disease
                                7.4.2.7.    Immunology
                                7.4.2.8.    Others

8.    Competitive Landscape           
       8.1.    Industry Attractiveness
       8.2.    Porter 5 Analysis
       8.3.    Major players and their key strategies
       8.4.    Company Share Analysis     

9.    Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional

       Companies of your Choice)
       9.1.    Sanofi
                  9.1.1.    Company Overview   
                  9.1.2.    Financials   
                  9.1.3.    Recent Developments   
       9.2.    F. Hoffmann-La Roche
                  9.2.1.    Company Overview   
                  9.2.2.    Financials   
                  9.2.3.    Recent Developments   
       9.3.    AbbVie Inc.
                  9.3.1.    Company Overview   
                  9.3.2.    Financials   
                  9.3.3.    Recent Developments   
       9.4.    Pfizer, Inc.
                  9.4.1.    Company Overview   
                  9.4.2.    Financials   
                  9.4.3.    Recent Developments   
       9.5.    Merck & Co., Inc.
                  9.5.1.    Company Overview   
                  9.5.2.    Financials   
                  9.5.3.    Recent Developments   
       9.6.    Novartis AG
                  9.6.1.    Company Overview   
                  9.6.2.    Financials   
                  9.6.3.    Recent Developments   
       9.7.    Johnson & Johnson
                  9.7.1.    Company Overview   
                  9.7.2.    Financials   
                  9.7.3.    Recent Developments   
       9.8.    GlaxoSmithKline
                  9.8.1.    Company Overview   
                  9.8.2.    Financials   
                  9.8.3.    Recent Developments   
       9.9.    Eli Lilly and Company
                  9.9.1.    Company Overview   
                  9.9.2.    Financials   
                  9.9.3.    Recent Developments
       9.10.    AstraZeneca PLC,
                  9.10.1.    Company Overview   
                  9.10.2.    Financials   
                  9.10.3.    Recent Developments

10.    About GMI Research